The Role of the Advanced Practice Provider in a Pericardial Center of Excellence.

IF 3.1 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Mary Heine, Ankit Agrawal, Emma Wensink, Tom Kai Ming Wang, Allan Klein
{"title":"The Role of the Advanced Practice Provider in a Pericardial Center of Excellence.","authors":"Mary Heine, Ankit Agrawal, Emma Wensink, Tom Kai Ming Wang, Allan Klein","doi":"10.1007/s11886-025-02205-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>Pericarditis can be a chronic and complex disease requiring years of treatment. These patients require close monitoring of labs, medications and their side effects, as well as virtual and inpatient follow up. Due to the complexity of this disease, many of these patients are treated for months and sometimes years. Our review highlights the role Advanced practice providers (APP) play in managing the complexity of these patients by providing efficient and quality care.</p><p><strong>Recent findings: </strong>Multi-modality cardiac imaging is the cornerstone to the evaluation and treatment of pericardial diseases. The addition of Interleukin (IL-1) blockers or biologics (Rilonacept, Anakinra) in the last few years provides targeted therapy for these patients. Using imaging guided therapy (IGT) these complex patients require close, continuous follow up and monitoring as well as frequent medication titration. The outcomes for these pericardial patients are improved with these centers due to the specialized medical and surgical care. Advanced Practice Providers play a vital role in a pericardial center with ordering the appropriate imaging and labs, handling medication titration, and providing patient education and continuity of care for these patients. They have been shown to decrease mortality, increase quality of care, and increase medication adherence.</p>","PeriodicalId":10829,"journal":{"name":"Current Cardiology Reports","volume":"27 1","pages":"69"},"PeriodicalIF":3.1000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Cardiology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11886-025-02205-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of review: Pericarditis can be a chronic and complex disease requiring years of treatment. These patients require close monitoring of labs, medications and their side effects, as well as virtual and inpatient follow up. Due to the complexity of this disease, many of these patients are treated for months and sometimes years. Our review highlights the role Advanced practice providers (APP) play in managing the complexity of these patients by providing efficient and quality care.

Recent findings: Multi-modality cardiac imaging is the cornerstone to the evaluation and treatment of pericardial diseases. The addition of Interleukin (IL-1) blockers or biologics (Rilonacept, Anakinra) in the last few years provides targeted therapy for these patients. Using imaging guided therapy (IGT) these complex patients require close, continuous follow up and monitoring as well as frequent medication titration. The outcomes for these pericardial patients are improved with these centers due to the specialized medical and surgical care. Advanced Practice Providers play a vital role in a pericardial center with ordering the appropriate imaging and labs, handling medication titration, and providing patient education and continuity of care for these patients. They have been shown to decrease mortality, increase quality of care, and increase medication adherence.

审查目的:心包炎可能是一种慢性复杂疾病,需要多年的治疗。这些患者需要密切监测化验结果、药物及其副作用,以及虚拟和住院随访。由于这种疾病的复杂性,许多患者需要接受数月甚至数年的治疗。我们的综述强调了高级医疗服务提供者(APP)通过提供高效、优质的医疗服务,在管理这些患者的复杂性方面所发挥的作用:多模态心脏成像是评估和治疗心包疾病的基石。过去几年中,白细胞介素(IL-1)阻断剂或生物制剂(Rilonacept、Anakinra)的加入为这些患者提供了靶向治疗。利用影像引导疗法(IGT),这些复杂的患者需要进行密切、持续的随访和监测,以及频繁的药物滴定。由于这些中心提供专业的医疗和外科护理,这些心包患者的治疗效果得到了改善。高级医疗服务提供者在心包中心发挥着至关重要的作用,他们可以为这些患者安排适当的影像学检查和化验、处理药物滴定、提供患者教育和持续护理。事实证明,他们可以降低死亡率、提高护理质量并增加用药依从性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Cardiology Reports
Current Cardiology Reports CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
6.20
自引率
2.70%
发文量
209
期刊介绍: The aim of this journal is to provide timely perspectives from experts on current advances in cardiovascular medicine. We also seek to provide reviews that highlight the most important recently published papers selected from the wealth of available cardiovascular literature. We accomplish this aim by appointing key authorities in major subject areas across the discipline. Section editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year. An Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research. We also provide commentaries from well-known figures in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信